1. Home
  2. ORN vs DCTH Comparison

ORN vs DCTH Comparison

Compare ORN & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Group Holdings Inc.

ORN

Orion Group Holdings Inc.

SELL

Current Price

$7.44

Market Cap

542.0M

Sector

Industrials

ML Signal

SELL

DCTH

Delcath Systems Inc.

SELL

Current Price

$19.89

Market Cap

578.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ORN
DCTH
Founded
1994
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
542.0M
578.4M
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
ORN
DCTH
Price
$7.44
$19.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$14.65
★ $28.60
AVG Volume (30 Days)
591.7K
★ 683.0K
Earning Date
10-27-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 220.00
107.53
EPS
0.15
★ 0.21
Revenue
★ $852,260,000.00
N/A
Revenue This Year
$10.18
$36.66
Revenue Next Year
$6.44
$20.12
P/E Ratio
★ $50.50
$98.76
Revenue Growth
★ 7.01
N/A
52 Week Low
$6.75
$8.12
52 Week High
$17.40
$22.51

Technical Indicators

Market Signals
Indicator
ORN
DCTH
Relative Strength Index (RSI) 40.52 66.17
Support Level $6.75 $10.76
Resistance Level $9.78 N/A
Average True Range (ATR) 0.67 1.15
MACD -0.05 0.67
Stochastic Oscillator 20.87 69.13

Price Performance

Historical Comparison
ORN
DCTH

About ORN Orion Group Holdings Inc.

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: